[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.120.181. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Editor's Correspondence
November 26, 2001

Pharmaceutical Manufacturer Sponsorship and Drug Information—Reply

Arch Intern Med. 2001;161(21):2626. doi:

In reply

Drs Basch and Bonfiglio present an elegant summary of the limitations of the PDR and the lack of awareness of many health professionals about these limitations. As they suggest, optimal therapeutics depends on complete information about the dose-response relationship of medications as well as on individualizing this information to the needs and characteristics of specific patients.

These doctors' faith in private publishers and electronic models is encouraging. There is no doubt that electronic resources have multiplied since Dr Paul Insel and I discussed the potential impact of these resources in our 1996 article on this topic.1

First Page Preview View Large
First page PDF preview
First page PDF preview
×